Press Coverage

Gilead's SPC for Truvada nullified by the Federal Patent Court (The SPC Blog)

The supplementary protection certificate of the US pharma company Gilead, which covers the active agent combination of the HIV medicament TRUVADA®, was nullified by the German Federal Patent Court (file no. 4 NI 12/17). Maiwald successfully represented the British generic producer Generics [UK] Ltd. in the nullity proceedings.

The complete article can be downloaded here: http://thespcblog.blogspot.com/2018/05/germany-gileads-spc-for-truvada.html

Newsletter